רקויפ מודוטאב 8 מ"ג

Country: Iżrael

Lingwa: Ebrajk

Sors: Ministry of Health

Ingredjent attiv:

ROPINIROLE AS HYDROCHLORIDE 8 MG

Disponibbli minn:

GLAXO SMITH KLINE (ISRAEL) LTD

Kodiċi ATC:

N04BC04

Għamla farmaċewtika:

FILM COATED TABLETS - PROLONGED RELEASE

Rotta amministrattiva:

PER OS

Manifatturat minn:

SMITHKLINE BEECHAM PLC, UK

Grupp terapewtiku:

ROPINIROLE

Indikazzjonijiet terapewtiċi:

Ropinirole is indicated for the treatment of Parkinson's disease. Ropinirole is effective as early therapy in patients requiring dopaminergic therapy. As adjunctive treatment to L-dopa, ropinirole enhances the efficacy of L-dopa, including control of "on-off" fluctuations and "end of dose" effects associated with chronic L-dopa therapy and permits reduction in daily L-dopa dose.

Data ta 'l-awtorizzazzjoni:

2009-09-01